Overview
Reporting to the SVP, Global Rare Business Unit, the Strategy and Operations Lead will have broad responsibility for strategic planning and operational coordination of Alnylam’s Global Rare Business Unit. S/he will serve as the primary “owner” of governance processes, developing the long-term vision for the BU, as well as supporting team culture initiatives.
S/he will cultivate operational excellence, drive clarity and simplify complexities within the Rare business via the tools of leadership team operations, governance, budgeting and collaboration/mutual trust between internal and external stakeholders (i.e. medical affairs, internal communications, HR, finance, key leaders, external partners). This individual serves as a key member of the Global Rare Commercial leadership team and will actively and energetically contribute to the Rare strategic vision, decision-making and execution as well as embody the values envisaged of company senior leaders.
Role based in Cambridge MA, 30% travel time in the US and internationally.
Key Responsibilities
- Develop and manage Rare Unit Governance Model
- Identify key meetings needs
- Oversee preparation for meetings (agendas, materials, action items)
- Collaborate with meeting owners of other key governance bodies to ensure potential duplication of effort/discussion is avoided and ensure the right discussions occur at the appropriate forums
- Prepare read out communications materials, designed to keep interested parties appraised and informed of the meeting while containing meeting size
- Coordinate and prepare Quarterly Business Reviews, monthly business reviews and any ad hoc business review (build slides, set-up meetings and help develop a clear, concise story)
- Lead and oversee annual planning and ongoing goal and resource tracking within Commercial
- Drive formation and tracking of Rare unit goals
- In collaboration with marketing, medical affairs, finance and others expertise areas, co-ordinate strategic and tactical planning, rare unit investment plan and LRP processes.
- Support tracking of priorities across the Global Rare Unit
- Develop roadmap of Global Rare Unit long term vision in collaboration with colleagues within department and business partners.
- Responsible for driving progress, reporting, identifying and mitigating risks, and issue escalation related to the overall goals
- Responsible to drive team culture related initiatives
- Liaise cross-functionally (Internal Communications, Legal, Finance, Procurement, HR, and other functions as necessary) to support efficient and timely execution of commercial objectives. Independently identify and resolve issues limiting execution with focus on simplification. Responsible for identifying, recommending, and executing process improvement initiatives within Global Rare Unit.
- Lead strategic projects to increase organizational and operational effectiveness
- Develop key strategic presentation for the SVP Head of Rare BU, including performance reviews, board decks, townhalls etc.
- Active and engaged member of the Global Rare Unit Leadership Team. Responsible for facilitation and participation in discussion and decision-making as well as meeting coordination: setting agenda, capturing and sharing minutes, assisting presenters with preparation for the meetings.
Qualifications
- Bachelor’s degree in scientific discipline or business with 8 years of experience in consulting with a focus on the biotechnology or pharmaceutical industry
- Strong budget, analytical, problem-solving, organization and communication skills.
- A highly driven, engaged and accomplished operational leader who demonstrates passion and a sense of urgency will thrive in this role.
Specific Qualifications Include
- Consulting background
- Excellent problem solving and execution skills with ability to multi-task
- Ability to build strong working relationships cross-functionally and across levels. Comfortable with interacting with senior internal and external stakeholders.
- Analytical skills
- Experience in forecasting and budget management.
- Strong written and oral communication skills.
- Sound judgment and discretion in sensitive matters.
- Ability to influence without authority.
- Thrives in highly entrepreneurial biotech environment and embraces Alnylam’s culture of science, passion and urgency.
- Intellectual curiosity, adaptability, and desire to learn and grow to meet the evolving needs of the organization.
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
